NovaBay Pharmaceuticals, Inc.

AMEX (USD): NovaBay Pharmaceuticals, Inc. (NBY)

Last Price

0.716

Today's Change

+0.219 (44.06%)

Day's Change

0.616 - 0.94

Trading Volume

103,713,362

Profile
NBY

Exchange:  American Stock Exchange American Stock Exchange

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Justin M. Hall Esq. Mr. Justin M. Hall Esq.

Full Time Employees:  24 24

IPO Date:  2007-10-26 2007-10-26

CIK:  0001389545 0001389545

ISIN:  US66987P3001 US66987P3001

CUSIP:  66987P201 66987P201

Beta:  0.73 0.73

Last Dividend:  0.00 0.00

Dcf Diff:  0.30 0.30

Dcf:  2.59 2.59

Description

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Address

2000 Powell Street,
EmeryVille, CA 94608, US

510 899 8800

http://novabay.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment